Tangen, Catherine M.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

Torkko, Kathleen, Till, Cathee, Tangen, Catherine M., Goodman, Phyllis J., Song, Xiaoling, Schenk, Jeannette M, Lucia, M. Scott, Peters, Ulrike, van Bokhoven, Adrie, Thompson, Ian M., Neuhouser, Maria

Journal:

Cancer Prevention Research

Year:

2020

File:

PDF, 860 KB

2020

2

Circadian genes and risk of prostate cancer in the prostate cancer prevention trial

Chu, Lisa W., Till, Cathee, Yang, Baiyu, Tangen, Catherine M., Goodman, Phyllis J., Yu, Kai, Zhu, Yong, Han, Summer, Hoque, Ashraful M., Ambrosone, Christine, Thompson, Ian, Leach, Robin, Hsing, Ann W

Journal:

Molecular Carcinogenesis

Year:

2018

Language:

english

File:

PDF, 345 KB

english, 2018

3

Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them

Gary G. Koch, Catherine M. Tangen, Jin-Whan Jung, Ingrid A. Amara

Journal:

Statistics in Medicine

Year:

1998

Language:

english

File:

PDF, 200 KB

english, 1998

4

Does the Level of Prostate Cancer Risk Affect Cancer Prevention with Finasteride?

Ian M. Thompson, Catherine M. Tangen, Howard L. Parnes, Scott M. Lippman, Charles A. Coltman Jr.

Journal:

Year:

2008

Language:

english

File:

PDF, 163 KB

english, 2008

5

Evaluation of Vitamin E and Selenium Supplementation for the Prevention of Bladder Cancer in SWOG Coordinated SELECT

Lotan, Yair, Goodman, Phyllis J., Youssef, Ramy F., Svatek, Robert S., Shariat, Shahrokh F., Tangen, Catherine M., Thompson, Ian M., Klein, Eric A.

Journal:

The Journal of Urology

Year:

2012

Language:

english

File:

PDF, 299 KB

english, 2012

6

Improved Overall Survival Trends of Men with Newly Diagnosed M1 Prostate Cancer: A SWOG Phase III Trial Experience (S8494, S8894 and S9346)

Tangen, Catherine M., Hussain, Maha H.A., Higano, Celestia S., Eisenberger, Mario A., Small, Eric J., Wilding, George, Donnelly, Bryan J., Schelhammer, Paul F., Crawford, E. David, Vogelzang, Nicholas

Journal:

The Journal of Urology

Year:

2012

Language:

english

File:

PDF, 548 KB

english, 2012

7

Statistical Design Issues and Other Practical Considerations for Conducting Phase III Prostate Cancer Prevention Trials

TANGEN, CATHERINE M., GOODMAN, PHYLLIS J., CROWLEY, JOHN J., THOMPSON, IAN M.

Journal:

The Journal of Urology

Year:

2004

Language:

english

File:

PDF, 628 KB

english, 2004

8

Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

Thompson, Ian M., Pauler, Donna K., Goodman, Phyllis J., Tangen, Catherine M., Lucia, M. Scott, Parnes, Howard L., Minasian, Lori M., Ford, Leslie G., Lippman, Scott M., Crawford, E. David, Crowley, J

Journal:

Boston Medical and Surgical Journal

Year:

2004

Language:

english

File:

PDF, 131 KB

english, 2004

9

The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcome

Vickers, Andrew J., Sjoberg, Daniel D., Ankerst, Donna P., Tangen, Catherine M., Goodman, Phyllis J., Thompson, Ian M.

Journal:

Year:

2013

Language:

english

File:

PDF, 137 KB

english, 2013

10

Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase III metastatic castration resistant prostate cancer trial

Goldkorn, Amir, Ely, Benjamin, Tangen, Catherine M., Tai, Yu-Chong, Xu, Tong, Li, Hongli, Twardowski, Przemyslaw, Veldhuizen, Peter J. Van, Agarwal, Neeraj, Carducci, Michael A., Monk, J. Paul, Garzot

Journal:

International Journal of Cancer

Year:

2015

Language:

english

File:

PDF, 328 KB

english, 2015

11

Effect of Finasteride on Serum Androstenedione and Risk of Prostate Cancer Within the Prostate Cancer Prevention Trial: Differential Effect on High- and Low-grade Disease

Hoque, Ashraful, Yao, Song, Till, Cathee, Kristal, Alan R., Goodman, Phyllis J., Hsing, Ann W., Tangen, Catherine M., Platz, Elizabeth A., Stanczyk, Frank Z., Reichardt, Juergen K.V., vanBokhoven, Adr

Journal:

Year:

2015

Language:

english

File:

PDF, 137 KB

english, 2015

12

Vitamin E and the Risk of Prostate Cancer

Klein, Eric A., Thompson, Ian M., Tangen, Catherine M., Crowley, John J., Lucia, M. Scott, Goodman, Phyllis J., Minasian, Lori M., Ford, Leslie G., Parnes, Howard L., Gaziano, J. Michael, Karp, Daniel

Journal:

JAMA The Journal of the American Medical Association

Year:

2011

Language:

english

File:

PDF, 358 KB

english, 2011

13

Evaluation of Ki67, p53 and angiogenesis in patients enrolled in a randomized study of neoadjuvant chemotherapy with or without cystectomy: A southwest oncology group study

Grossman, H., Tangen, Catherine, Cordon-Cardo, Carlos, Cote, Richard, Waldman, Frederic, De Vere White, Ralph, Karnad, Anand, Glode, Michael, Crawford, E.

Journal:

Oncology Reports

Year:

2006

Language:

english

File:

PDF, 69 KB

english, 2006

14

Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial

Unger, Joseph M, Hershman, Dawn L, Till, Cathee, Tangen, Catherine M, Barlow, William E, Ramsey, Scott D, Goodman, Phyllis J, Thompson, Ian M

Journal:

JNCI Journal of the National Cancer Institute

Year:

2018

Language:

english

File:

PDF, 766 KB

english, 2018

15

Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non–Muscle-Invasive Bladder Cancer on Tumor Recurrence

Messing, Edward M., Tangen, Catherine M., Lerner, Seth P., Sahasrabudhe, Deepak M., Koppie, Theresa M., Wood, David P., Mack, Philip C., Svatek, Robert S., Evans, Christopher P., Hafez, Khaled S., Cul

Journal:

JAMA The Journal of the American Medical Association

Year:

2018

Language:

english

File:

PDF, 428 KB

english, 2018

16

Non-parametric covariance methods for incidence density analyses of time-to-event data from a randomized clinical trial and their complementary roles to proportional hazards regression

Catherine M. Tangen, Gary G. Koch

Journal:

Statistics in Medicine

Year:

2000

Language:

english

File:

PDF, 164 KB

english, 2000

17

Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid

Ronald M. Bukowski, Catherine M. Tangen, Robert F. Peterson, Thomas R. Fleming, Sarah A. Taylor, John J. Rinehart, Harmon J. Eyre, Saul E. Rivkin, John S. Macdonald

Journal:

Year:

1994

Language:

english

File:

PDF, 347 KB

english, 1994

18

Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. A southwest oncology group study

Jeffrey L. Berenberg, Catherine Tangen, John S. Macdonald, Laura F. Hutchins, Ronald B. Natale, Noboru Oishi, Jerry T. Guy, Thomas R. Fleming

Journal:

Year:

1995

Language:

english

File:

PDF, 419 KB

english, 1995

19

Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase

Alan R. Kristal, Chen Chi, Catherine M. Tangen, Phyllis J. Goodman, Ruth Etzioni, Ian M. Thompson

Journal:

Year:

2006

Language:

english

File:

PDF, 121 KB

english, 2006

20

Southwest oncology group phase II study of arsenic trioxide in patients with refractory germ cell malignancies

Tomasz M. Beer, Catherine M. Tangen, Craig R. Nichols, Kim A. Margolin, Robert Dreicer, William T. Stephenson, David I. Quinn, Derek Raghavan, E. David Crawford

Journal:

Year:

2006

Language:

english

File:

PDF, 78 KB

english, 2006

21

The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer : A Multivariate Analysis of Southwest Oncology Group Study 8894

Tomasz M. Beer, Catherine M. Tangen, Lisa B. Bland, Maha Hussain, Bryan H. Goldman, Thomas G. DeLoughery, E. David Crawford

Journal:

Year:

2006

Language:

english

File:

PDF, 140 KB

english, 2006

22

Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin : Report of Southwest Oncology Group Trial 8733

Celestia S. Higano, Catherine M. Tangen, Wael A. Sakr, James Faulkner, Saul E. Rivkin, Frederick J. Meyers, Maha Hussain, Laurence H. Baker, Kenneth J. Russell, E. David Crawford

Journal:

Year:

2008

Language:

english

File:

PDF, 162 KB

english, 2008

23

Antiandrogen withdrawal in castrate-refractory prostate cancer : A Southwest Oncology Group trial (SWOG 9426)

A. Oliver Sartor, Catherine M. Tangen, Maha H. A. Hussain, Mario A. Eisenberger, Minoti Parab, Joseph A. Fontana, Robert A. Chapman, Glenn M. Mills, Derek Raghavan, E. David Crawford

Journal:

Year:

2008

Language:

english

File:

PDF, 143 KB

english, 2008

24

Alcohol consumption, finasteride, and prostate cancer risk : Results from the prostate cancer prevention trial

Zhihong Gong, Alan R. Kristal, Jeannette M. Schenk, Catherine M. Tangen, Phyllis J. Goodman, Ian M. Thompson

Journal:

Year:

2009

Language:

english

File:

PDF, 142 KB

english, 2009

25

Adjuvant continuous infusion 5-FU, whole-abdominal radiation, and tumor bed boost in high-risk stage III colon carcinoma: A southwest oncology group pilot study

Carol Fabian, Shankar Giri, Norman Estes, Catherine M. Tangen, Elizabeth Poplin, Stanley Vogel, Wendall Goodwin, Saul Rivkin, Thomas R. Fleming, John S. Macdonald

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

1995

Language:

english

File:

PDF, 702 KB

english, 1995

26

SWOG-9510: evaluation of topotecan in hormone refractory prostate cancer: A southwest oncology group study

Catherine E. Klein, Catherine M. Tangen, Thomas J. Braun, Maha H.A. Hussain, David M. Peereboom, Craig R. Nichols, Saul E. Rivkin, Shaker R. Dakhil, E. David Crawford

Journal:

Year:

2002

Language:

english

File:

PDF, 74 KB

english, 2002

27

Finasteride, prostate cancer, and weight gain: Evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment

YoonJu Song, Catherine Tangen, Phyllis Goodman, Howard L. Parnes, M. Scott Lucia, Ian M. Thompson, Alan R. Kristal

Journal:

Year:

2008

Language:

english

File:

PDF, 108 KB

english, 2008

28

Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial

Marian L. Neuhouser, Jeannette Schenk, Yoon Ju Song, Catherine M. Tangen, Phyllis J. Goodman, Michael Pollak, David F. Penson, Ian M. Thompson, Alan R. Kristal

Journal:

Year:

2008

Language:

english

File:

PDF, 117 KB

english, 2008

29

Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial

Jeannette M. Schenk, Alan R. Kristal, Marian L. Neuhouser, Catherine M. Tangen, Emily White, Daniel W. Lin, Ian M. Thompson

Journal:

Year:

2009

Language:

english

File:

PDF, 104 KB

english, 2009

30

Non-parametric analysis of covariance for confirmatory randomized clinical trials to evaluate dose–response relationships

Catherine M. Tangen, Gary G. Koch

Journal:

Statistics in Medicine

Year:

2001

Language:

english

File:

PDF, 157 KB

english, 2001

31

Hepatoma/merbarone

Elizabeth A. Poplin, Catherine M. Tangen, Walter H. Harvey, John S. Macdonald

Journal:

Investigational New Drugs

Year:

1994

Language:

english

File:

PDF, 287 KB

english, 1994

32

VM-26 in gastric cancer

Jeffrey L. Berenberg, Catherine Tangen, John S. Macdonald, Bart Barlogie, Leslie Rogers Laufman

Journal:

Investigational New Drugs

Year:

1993

Language:

english

File:

PDF, 160 KB

english, 1993

33

Phase II trial of piroxantrone in gastric carcinoma

Alexander Hantel, Catherine Tangen, William L. Gluck, John S. Macdonald

Journal:

Investigational New Drugs

Year:

1994

Language:

english

File:

PDF, 238 KB

english, 1994

34

Phase II trial of trimetrexate in untreated advanced gastric carcinoma

Alexander Hantel, Catherine M. Tangen, John S. Macdonald, Stephen P. Richman, Reginald P. Pugh, Theodore Pollock

Journal:

Investigational New Drugs

Year:

1994

Language:

english

File:

PDF, 221 KB

english, 1994

35

A phase II trial of piroxantrone in adenocarcinoma of the pancreas

Terry R. Jenkins, Catherine Tangen, John S. Macdonald, Geoffrey Weiss, Robert Chapman, Alexander Hantel

Journal:

Investigational New Drugs

Year:

1993

Language:

english

File:

PDF, 180 KB

english, 1993

36

The Prostate Cancer Prevention Trial: design, status, and promise

Ian M. Thompson, Catherine Tangen, Phyllis Goodman

Journal:

World Journal of Urology

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

37

Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case–control study

Song Yao, Cathee Till, Alan R. Kristal, Phyllis J. Goodman, Ann W. Hsing, Catherine M. Tangen, Elizabeth A. Platz, Frank Z. Stanczyk, Juergen K. V. Reichardt, Li Tang, Marian L. Neuhouser, Regina M. S

Journal:

Cancer Causes & Control

Year:

2011

Language:

english

File:

PDF, 190 KB

english, 2011

38

THE PROSTATE CANCER PREVENTION TRIAL AND THE FUTURE OF CHEMOPREVENTION

Ian M. Thompson, Catherine M. Tangen, M. Scott Lucia

Journal:

BJU International

Year:

2008

Language:

english

File:

PDF, 95 KB

english, 2008

39

Results of the Southwest Oncology Group phase II evaluation (study S0031) of ZD1839 for advanced transitional cell carcinoma of the urothelium

Daniel P. Petrylak, Catherine M. Tangen, Peter J. Van Veldhuizen Jr, J. Wendall Goodwin, Przemyslaw W. Twardowski, James N. Atkins, Shaker R. Kakhil, Marianne K. Lange, Mahesh Mansukhani, E. David Cra

Journal:

BJU International

Year:

2010

Language:

english

File:

PDF, 260 KB

english, 2010

40

The Influence of Finasteride on the Development of Prostate Cancer

Thompson, Ian M., Goodman, Phyllis J., Tangen, Catherine M., Lucia, M. Scott, Miller, Gary J., Ford, Leslie G., Lieber, Michael M., Cespedes, R. Duane, Atkins, James N., Lippman, Scott M.

Journal:

Boston Medical and Surgical Journal

Year:

2003

Language:

english

File:

PDF, 120 KB

english, 2003

41

Implementation of the Prostate Cancer Prevention Trial (PCPT)

Phyllis J Goodman, Catherine M Tangen, John J Crowley, Susan M Carlin, Anne Ryan, Charles A Coltman Jr., Leslie G Ford, Ian M Thompson

Journal:

Controlled Clinical Trials

Year:

2004

Language:

english

File:

PDF, 284 KB

english, 2004

42

Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia

Willem J Kop, John S Gottdiener, Catherine M Tangen, Linda P Fried, Mary Ann McBurnie, Jeremy Walston, Anne Newman, Calvin Hirsch, Russell P Tracy

Journal:

The American Journal of Cardiology

Year:

2002

Language:

english

File:

PDF, 134 KB

english, 2002

43

Editorial comment 1

Ian M. Thompson Jr, Catherine M. Tangen

Journal:

Year:

2004

Language:

english

File:

PDF, 51 KB

english, 2004

44

Ten-year Follow-up of Neoadjuvant Therapy with Goserelin Acetate and Flutamide Before Radical Prostatectomy for Clinical T3 and T4 Prostate Cancer: Update on Southwest Oncology Group Study 9109

Ryan K. Berglund, Catherine M. Tangen, Isaac J. Powell, Bruce A. Lowe, Gabriel P. Haas, Peter R. Carroll, Edith D. Canby-Hagino, Ralph deVere White, George P. Hemstreet III, E. David Crawford, Ian M.

Journal:

Year:

2012

Language:

english

File:

PDF, 341 KB

english, 2012

45

A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: A Southwest Oncology Group Study

Michael F. Sarosdy, Catherine M. Tangen, Geoffrey R. Weiss, Blake R. Nestok, Mitchell C. Benson, Paul F. Schellhammer, Arthur I. Sagalowsky, David P. Wood Jr., E. David Crawford

Journal:

Urologic Oncology: Seminars and Original Investigations

Year:

2005

Language:

english

File:

PDF, 142 KB

english, 2005

46

Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer

Seth P. Lerner, Catherine M. Tangen, Heidi Sucharew, David Wood, E. David Crawford

Journal:

Urologic Oncology: Seminars and Original Investigations

Year:

2009

Language:

english

File:

PDF, 316 KB

english, 2009

47

Ten-Year Survival in Patients with Metastatic Prostate Cancer

Tangen, Catherine M., Faulkner, James R., Crawford, E. David, Thompson, Ian M., Hirano, Daisaku, Eisenberger, Mario, Hussain, Maha

Journal:

Clinical Prostate Cancer

Year:

2003

Language:

english

File:

PDF, 121 KB

english, 2003

48

The Impact of Prostate Volume, Number of Biopsy Cores and American Urological Association Symptom Score on the Sensitivity of Cancer Detection Using the Prostate Cancer Prevention Trial Risk Calculator

Ankerst, Donna P., Till, Cathee, Boeck, Andreas, Goodman, Phyllis, Tangen, Catherine M., Feng, Ziding, Partin, Alan W., Chan, Daniel W., Sokoll, Lori, Kagan, Jacob, Wei, John T., Thompson, Ian M.

Journal:

The Journal of Urology

Year:

2013

Language:

english

File:

PDF, 974 KB

english, 2013

49

Intermittent versus Continuous Androgen Deprivation in Prostate Cancer

Hussain, Maha, Tangen, Catherine M., Berry, Donna L., Higano, Celestia S., Crawford, E. David, Liu, Glenn, Wilding, George, Prescott, Stephen, Kanaga Sundaram, Subramanian, Small, Eric Jay, Dawson, Na

Journal:

Boston Medical and Surgical Journal

Year:

2013

Language:

english

File:

PDF, 1.02 MB

english, 2013

50

Long-Term Survival of Participants in the Prostate Cancer Prevention Trial

Thompson, Ian M., Goodman, Phyllis J., Tangen, Catherine M., Parnes, Howard L., Minasian, Lori M., Godley, Paul A., Lucia, M. Scott, Ford, Leslie G.

Journal:

New England Journal of Medicine

Year:

2013

Language:

english

File:

PDF, 666 KB

english, 2013